Implementation of New Exercise Protocols in Cardiac Rehabilitation.

Status

Not yet recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07161219

Acronym

REVACARD

Enrollment

Registered

2025-09-08

Start date

2025-12-01

Completion date

2029-12-31

Last updated

2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Disease, Heart Diseases, Inspiratory Muscle Training

Keywords

heart failure, inspiratory muscles training

Brief summary

* Primary Objective: To evaluate the effects of complementary exercise protocols in cardiac rehabilitation (CR), such as inspiratory muscle training (IMT), by assessing inspiratory muscle strength. * Secondary Objectives: To assess functional capacity, quality of life (QoL), and pulmonary function.

Interventions

DEVICEinspiratory muscle training

inspiratory muscle training for intervention group

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Intervention model description

randomized control trial

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

\- Patient meeting the conditions of the permanent life support agreement following hospitalization for a cardiac condition such as: acute myocardial infarction; coronary surgery; therapeutic percutaneous endovascular intervention on the coronary arteries, under medical imaging guidance; therapeutic percutaneous endovascular intervention on the heart, under medical imaging guidance; surgery for congenital or acquired heart malformation; surgery for valvular lesion; heart transplantation; resistant angina (to be specified by detailed history, medical history, and technical examinations, justifying multidisciplinary care); cardiomyopathy with left ventricular dysfunction (to be specified by detailed history, medical history, and technical examinations, justifying multidisciplinary care). * Patient aged between 18 and 80 years. * Patient capable of giving informed consent. * Patient registered for permanent life support at the CuSL. * Patient capable of understanding instructions in French. - Patient with prior medical consent and clinically stable.

Exclusion criteria

* \- Minor (\<18 years old). * Pregnant woman. * Patient unable to provide informed consent. * Patient with cognitive, neurological, or orthopedic limitations. * Patient with mobility or musculoskeletal difficulties incompatible with physical activity. * Clinical instability.

Design outcomes

Primary

Measure	Time frame
Maximal inspiratory pressure	1 year

Contacts

Primary ContactSabrina Fernandez, PT

sabrina.fernandez@saintluc.uclouvain.be027649938

Backup ContactMartin Dayez, PT

martin.dayez@saintluc.uclouvain.be027646043

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026